Related Experiment Video
Updated: Jun 3, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Papillomaviruses and assays for transforming genes
1Ludwig Institute, St. Mary's Hospital, London, UK.
Human papillomavirus (HPV) research has a long history, revealing its role in benign warts and its significant link to certain human cancers. Understanding HPV's oncogenic potential is crucial for cancer research.
Area of Science:
- Virology
- Oncology
- Dermatology
Background:
- Human papillomavirus (HPV) research began with identifying it as the cause of human warts.
- Recent interest stems from HPV's established role in the development of specific human cancers.
- Papillomaviruses, including HPV, have demonstrated oncogenic potential, progressing benign lesions to malignancy.
Purpose of the Study:
- To review the historical context and significance of human papillomavirus (HPV) research.
- To highlight the link between papillomaviruses and cancer development.
- To discuss the challenges and historical progression of HPV research.
Main Methods:
- Historical literature review.
- Analysis of early and recent studies on papillomaviruses and cancer.
- Examination of factors influencing tumor progression models.
Main Results:
- HPV was identified as the infectious agent causing human warts.
- A strong association between certain HPVs and human cancers has been established.
- The cottontail rabbit papillomavirus model demonstrated progression from benign to malignant lesions.
Conclusions:
- HPV research has evolved from understanding warts to recognizing its critical role in oncogenesis.
- The study of papillomavirus-induced malignancy provides a valuable model for tumor progression.
- Historical research challenges, such as the lack of in vitro culture systems, have impacted the pace of discovery.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020